Heart ultrasound gets a boost: new contrast agent aims for sharper images

NCT ID NCT06815627

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This Phase 3 trial tests whether NH002, a contrast agent made of tiny gas-filled microspheres, can improve the quality of heart ultrasound images in people with heart disease. Participants receive NH002 through an IV before a standard echocardiogram. The study compares the clarity of heart chamber borders and overall image quality with and without the contrast agent. The goal is to see if NH002 helps doctors get clearer, more reliable images of the heart.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NH002 (Perflutren Lipid Microspheres) Injectable Suspension
What this could lead to
If successful, NH002 could make heart ultrasounds more accurate, helping doctors see heart structure and function better without more invasive tests.
What could go wrong
This is a Phase 3 trial with 150 participants, so results may not apply to everyone. The contrast agent may cause side effects like allergic reactions or temporary discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cathay General Hospital

    Taipei, 106438, Taiwan

  • China Medical University Hospital

    Taichung, 404327, Taiwan

  • Keelung Chang Gung Memorial Hospital & Lovers Lake Branch

    Keelung, 204201, Taiwan

  • MacKay Memorial Hospital

    Taipei, 104217, Taiwan

  • National Taiwan University Hospital Hsin-Chu Branch

    Zhubei, 302058, Taiwan

  • Taipei Veterans General Hospital

    Taipei, 11217, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.